Effectiveness and safety of switching to entecavir hepatitis B patients developing kidney dysfunction during tenofovir
Articolo
Data di Pubblicazione:
2018
Abstract:
Tenofovir disoproxil fumarate (TDF) is recommended for chronic hepatitis B (CHB) treatment, but it may induce kidney dysfunction whose management is not yet known. This Italian, multicentre, retrospective study aimed to assess the efficacy and safety of switching to entecavir (ETV) patients who developed TDF-associated glomerular and/or tubular dysfunction.
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
Hepatitis B virus; liver; liver function tests; renal dysfunction; viral hepatitis
Elenco autori:
Viganò, Mauro; Loglio, Alessandro; Labanca, Sara; Zaltron, Serena; Castelli, Francesco; Andreone, Pietro; Messina, Vincenzo; Ganga, Roberto; Coppola, Nicola; Marrone, Aldo; Russello, Maurizio; Marzano, Alfredo; Tucci, Alessandra; Taliani, Gloria; Fasano, Massimo; Fagiuoli, Stefano; Villa, Erica; Bronte, Fabrizio; Santantonio, Teresa; Brancaccio, Giuseppina; Occhipinti, Vincenzo; Facchetti, Floriana; Grossi, Glenda; Rumi, Mariagrazia; Lampertico, Pietro
Link alla scheda completa:
Pubblicato in: